Reserve Petroleum Co
OTC:RSRV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Reserve Petroleum Co
OTC:RSRV
|
US |
|
Gentera SAB de CV
BMV:GENTERA
|
MX |
|
M
|
Merck KGaA
OTC:MKGAF
|
DE |
|
Beijing Huafeng Test & Control Technology Co Ltd
SSE:688200
|
CN |
Balance Sheet
Balance Sheet Decomposition
Reserve Petroleum Co
Reserve Petroleum Co
Balance Sheet
Reserve Petroleum Co
| Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
1
|
3
|
10
|
11
|
11
|
15
|
14
|
8
|
5
|
6
|
3
|
16
|
10
|
7
|
5
|
4
|
2
|
|
| Cash Equivalents |
1
|
1
|
1
|
1
|
3
|
10
|
11
|
11
|
15
|
14
|
8
|
5
|
6
|
3
|
16
|
10
|
7
|
5
|
4
|
2
|
|
| Short-Term Investments |
8
|
13
|
15
|
16
|
14
|
7
|
7
|
7
|
7
|
9
|
14
|
17
|
17
|
19
|
4
|
9
|
7
|
5
|
3
|
5
|
|
| Total Receivables |
3
|
2
|
3
|
2
|
2
|
3
|
2
|
3
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
|
| Accounts Receivables |
3
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
|
| Other Receivables |
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
12
|
16
|
20
|
19
|
19
|
20
|
20
|
21
|
25
|
24
|
23
|
23
|
24
|
23
|
22
|
21
|
16
|
13
|
9
|
10
|
|
| PP&E Net |
5
|
8
|
9
|
8
|
9
|
13
|
15
|
19
|
18
|
12
|
11
|
11
|
11
|
10
|
7
|
8
|
15
|
15
|
21
|
27
|
|
| PP&E Gross |
5
|
8
|
9
|
8
|
9
|
13
|
15
|
19
|
18
|
12
|
11
|
11
|
11
|
10
|
7
|
8
|
15
|
15
|
21
|
27
|
|
| Accumulated Depreciation |
7
|
8
|
13
|
17
|
19
|
21
|
26
|
31
|
37
|
43
|
45
|
46
|
46
|
48
|
50
|
53
|
53
|
58
|
63
|
67
|
|
| Long-Term Investments |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
3
|
5
|
8
|
8
|
6
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
18
N/A
|
25
+41%
|
29
+17%
|
29
-1%
|
29
-1%
|
34
+17%
|
36
+7%
|
40
+13%
|
44
+9%
|
38
-14%
|
37
-3%
|
36
-2%
|
38
+5%
|
36
-6%
|
32
-10%
|
33
+3%
|
39
+17%
|
36
-6%
|
36
0%
|
42
+14%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Liabilities |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Deferred Income Tax |
0
|
0
|
1
|
1
|
2
|
3
|
3
|
4
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
3
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
3
|
3
|
2
|
3
|
|
| Total Liabilities |
2
N/A
|
2
+53%
|
4
+51%
|
3
-5%
|
4
+29%
|
6
+32%
|
7
+17%
|
7
+6%
|
7
+4%
|
5
-33%
|
5
-6%
|
4
-11%
|
4
+5%
|
4
-18%
|
3
-23%
|
3
+24%
|
6
+89%
|
6
-10%
|
6
+2%
|
8
+32%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
16
|
23
|
26
|
26
|
25
|
29
|
30
|
34
|
38
|
34
|
34
|
33
|
35
|
34
|
31
|
31
|
34
|
32
|
33
|
36
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Total Equity |
16
N/A
|
23
+40%
|
26
+14%
|
26
0%
|
24
-5%
|
28
+15%
|
29
+5%
|
33
+14%
|
37
+10%
|
33
-10%
|
32
-3%
|
32
0%
|
34
+5%
|
32
-4%
|
29
-9%
|
30
+1%
|
32
+8%
|
31
-5%
|
30
0%
|
34
+11%
|
|
| Total Liabilities & Equity |
18
N/A
|
25
+41%
|
29
+17%
|
29
-1%
|
29
-1%
|
34
+17%
|
36
+7%
|
40
+13%
|
44
+9%
|
38
-14%
|
37
-3%
|
36
-2%
|
38
+5%
|
36
-6%
|
32
-10%
|
33
+3%
|
39
+17%
|
36
-6%
|
36
0%
|
42
+14%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|